tiprankstipranks

Vitrafy Life Sciences Announces Director’s Share Acquisition

Story Highlights
  • Vitrafy Life Sciences announced a change in director’s interest involving John McBain.
  • 28,255 ordinary shares were acquired through an on-market trade at $1.3603 per share.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Vitrafy Life Sciences Announces Director’s Share Acquisition

The latest update is out from Vitrafy Life Sciences Ltd. ( (AU:VFY) ).

Vitrafy Life Sciences Limited has announced a change in the director’s interest, specifically involving John McBain. The change was due to an on-market trade where 28,255 ordinary shares were acquired at a price of $1.3603 per share. This adjustment in shareholding reflects a strategic move within the company, potentially impacting its market dynamics and stakeholder interests.

More about Vitrafy Life Sciences Ltd.

YTD Price Performance: -20.0%

Average Trading Volume: 25,643

Find detailed analytics on VFY stock on TipRanks’ Stock Analysis page.

Questions or Comments about the article? Write to editor@tipranks.com

Questions or Comments about the article? Write to editor@tipranks.com
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App